Pituitary apoplexy
Pituitary apoplexy is sudden hemorrhage or infarction of a pituitary adenoma causing severe headache, visual loss, ophthalmoplegia, and acute adrenocorticotropic hormone (ACTH) deficiency, and is a medical emergency. First-line treatment is immediate IV hydrocortisone given empirically before confirmatory testing when adrenal insufficiency is suspected, with urgent pituitary MRI and surgical decompression reserved for progressive visual loss.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Definition: pituitary apoplexy is sudden hemorrhage or infarction of a pituitary adenoma, most often a nonfunctioning macroadenoma that has outgrown its blood supply.
- Epidemiology
Occurs almost exclusively in the setting of a pituitary adenoma: most substrate tumors are nonfunctioning macroadenomas, which are often clinically silent until the apoplectic event.
- Risk factors
Underlying pituitary adenoma, particularly a macroadenoma: the enlarging, vascularly fragile tumor is the substrate for hemorrhage or infarction.
- Pathophysiology
A rapidly growing or vascularly compromised adenoma outgrows its blood supply, leading to hemorrhagic infarction of the tumor and adjacent normal pituitary tissue.
- Clinical features
Sudden, severe headache is the hallmark and near-universal presenting symptom, often described as the worst headache of the patient's life (a thunderclap pattern).
- Differential diagnosis
Subarachnoid hemorrhage: also a thunderclap headache, but without the bitemporal visual field defect of chiasm compression, and confirmed by noncontrast CT or lumbar puncture for xanthochromia rather than a sellar mass.
- Diagnosis
The diagnosis is established clinically, by the acute triad of severe headache, visual disturbance or ophthalmoplegia, and biochemical evidence of hypocortisolemia in a patient with a pituitary mass…
- Management
First, if adrenal insufficiency is suspected (relative hypotension, hyponatremia, or any evidence of hypocortisolemia), give immediate IV hydrocortisone without waiting for confirmatory testing…
- Complications
Acute adrenal crisis and cardiovascular collapse from unrecognized or inadequately treated ACTH deficiency, which can be fatal.
- Prognosis
Outcome is closely tied to time to treatment, particularly for visual recovery, which is more likely when decompression is performed promptly after visual loss develops.
- Prevention
Evaluate for pituitary hormone deficiency in every patient with a known pituitary tumor, regardless of symptoms, with FSH, LH, cortisol, TSH, free T4, and total testosterone in men, so that a baseline is available if apoplexy later occurs.
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Nonfunctioning pituitary adenoma
A nonfunctioning pituitary adenoma is a benign pituitary tumor, usually of gonadotroph origin, that does not secrete a clinically excessive hormone and presents through mass effect (visual field loss, headache) or hypopituitarism rather than a hypersecretory syndrome. Diagnosis requires excluding hormone excess and screening for hypopituitarism; treatment is observation for a small asymptomatic incidentaloma or transsphenoidal surgery for mass effect, apoplexy, or growth on follow-up.
- Sheehan syndrome
Sheehan syndrome is postpartum pituitary infarction after massive obstetric hemorrhage, causing panhypopituitarism with failure of lactation and deficiencies of glucocorticoids, thyroid hormone, and sex hormones. First-line treatment is glucocorticoid replacement started before thyroid hormone, followed by levothyroxine and, when indicated, sex hormone and growth hormone replacement.
- Lymphocytic hypophysitis
Lymphocytic hypophysitis is a presumed autoimmune inflammation of the pituitary gland that typically presents in women during pregnancy or the postpartum period, with a sellar mass, hyperprolactinemia, or hypopituitarism. There is no specific therapy; management is hormonal replacement of any deficient axis as needed, with surgery reserved for mass effect that does not respond to observation.